JP2024516613A5 - - Google Patents
Info
- Publication number
- JP2024516613A5 JP2024516613A5 JP2023564508A JP2023564508A JP2024516613A5 JP 2024516613 A5 JP2024516613 A5 JP 2024516613A5 JP 2023564508 A JP2023564508 A JP 2023564508A JP 2023564508 A JP2023564508 A JP 2023564508A JP 2024516613 A5 JP2024516613 A5 JP 2024516613A5
- Authority
- JP
- Japan
- Prior art keywords
- linker
- cpmb
- conjugate according
- gal
- fam
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNPCT/CN2021/089305 | 2021-04-23 | ||
| CN2021089305 | 2021-04-23 | ||
| PCT/CN2022/088117 WO2022222986A1 (en) | 2021-04-23 | 2022-04-21 | Cyclic peptide-n-acetylgalactosamine (galnac) conjugates for drug delivery to liver cells |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024516613A JP2024516613A (ja) | 2024-04-16 |
| JP2024516613A5 true JP2024516613A5 (enExample) | 2025-04-25 |
Family
ID=83723528
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023564508A Pending JP2024516613A (ja) | 2021-04-23 | 2022-04-21 | 肝臓細胞への薬物送達のための環状ペプチド－Ｎ－アセチルガラクトサミン（ＧａｌＮＡｃ）コンジュゲート |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240218023A1 (enExample) |
| EP (1) | EP4326744A4 (enExample) |
| JP (1) | JP2024516613A (enExample) |
| KR (1) | KR20240044385A (enExample) |
| CN (1) | CN117529490A (enExample) |
| AU (1) | AU2022261265A1 (enExample) |
| IL (1) | IL307882A (enExample) |
| WO (1) | WO2022222986A1 (enExample) |
| ZA (1) | ZA202309922B (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024117938A1 (ru) * | 2022-11-30 | 2024-06-06 | Общество с ограниченной ответственностью "СИСТЕМА-БИОТЕХ" | Способы получения биоконъюгатов для печень-специфической направленной модуляции протеома |
| WO2024152775A1 (zh) * | 2023-01-17 | 2024-07-25 | 云合智药（苏州）生物科技有限公司 | 缀合物、配体单元及其用途 |
| WO2025016294A1 (zh) * | 2023-07-14 | 2025-01-23 | 云合智药（苏州）生物科技有限公司 | 用于抑制己酮糖激酶表达的RNAi剂及其应用 |
| CN120040554B (zh) * | 2025-04-25 | 2025-07-18 | 云合智药（苏州）生物科技有限公司 | 环肽类肝靶向化合物、药物组合物及其用途 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE350393T1 (de) * | 2002-09-19 | 2007-01-15 | Centre Nat Rech Scient | Synthese und charakterisierung neuer systeme zum hinführen und zur vektorisierung von molekülen von therapeutischem interesse zu targetzellen |
| FR2959993B1 (fr) * | 2010-05-17 | 2014-10-17 | Commissariat Energie Atomique | Nouveaux composes cyclodecapeptides et leurs applications |
| US8501930B2 (en) * | 2010-12-17 | 2013-08-06 | Arrowhead Madison Inc. | Peptide-based in vivo siRNA delivery system |
| WO2019217682A1 (en) * | 2018-05-09 | 2019-11-14 | Ohio State Innovation Foundation | Cyclic cell-penetrating peptides with one or more hydrophobic residues |
-
2022
- 2022-04-21 EP EP22791092.4A patent/EP4326744A4/en active Pending
- 2022-04-21 US US18/556,040 patent/US20240218023A1/en active Pending
- 2022-04-21 JP JP2023564508A patent/JP2024516613A/ja active Pending
- 2022-04-21 IL IL307882A patent/IL307882A/en unknown
- 2022-04-21 WO PCT/CN2022/088117 patent/WO2022222986A1/en not_active Ceased
- 2022-04-21 CN CN202280043909.8A patent/CN117529490A/zh active Pending
- 2022-04-21 KR KR1020237040193A patent/KR20240044385A/ko active Pending
- 2022-04-21 AU AU2022261265A patent/AU2022261265A1/en active Pending
-
2023
- 2023-10-24 ZA ZA2023/09922A patent/ZA202309922B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12285462B2 (en) | pH-triggered membrane peptide-mediated epitope tethering at cell surfaces | |
| ES2588436T3 (es) | Análogos de interferón | |
| JP5390621B2 (ja) | 二座ペプチドバインダー | |
| JP2023506757A5 (enExample) | ||
| CA2304254A1 (en) | Trimerising module | |
| JP7846169B2 (ja) | 細胞透過性ペプチド | |
| EP2145898A1 (en) | Anti-amyloid immunogenic compositions, methods and uses | |
| AU2011302645B2 (en) | Systems and methods of delivery of bioactive agents using bacterial toxin-derived transport sequences | |
| PE20231506A1 (es) | Peptidos y combinaciones de peptidos para su uso en inmunoterapia contra una infeccion por sars-cov-2 (covid-19) | |
| JP2023532290A5 (enExample) | ||
| US10202469B2 (en) | Sugar chain-attached linker, compound containing sugar chain-attached linker and physiologically active substance or salt thereof, and method for producing same | |
| JP2024516613A (ja) | 肝臓細胞への薬物送達のための環状ペプチド－Ｎ－アセチルガラクトサミン（ＧａｌＮＡｃ）コンジュゲート | |
| JP2022517236A (ja) | 自己組織化ペプチドナノ粒子およびその使用 | |
| JP2023503797A (ja) | 分子ガイドシステムペプチド及びその使用 | |
| JP2024036461A (ja) | 自己集合ペプチド骨格 | |
| JP2021501798A (ja) | アルブミンとの強化された結合親和性を有する医薬構築物 | |
| JP2003500334A (ja) | 抗ｈｉｖ作用を有するｒａｎｔｅｓ由来ペプチド | |
| WO2002077025A1 (en) | Peptide analogues of myelin basic protein epitopes in the treatment of experimental autoimmune encephalomyelitis (eae) and multiple sclerosis (ms) | |
| US20140336127A1 (en) | Stabilized Peptide Helices For Inhibiting Dimerization Of Chemokine C Motif Receptor 2 (CCR2) | |
| US20170081375A1 (en) | Generation of brain and spinal cord neurons, cardiac myocytes, renal nephrons and hepatocytes using reg peptides, peptidomimetics, small molecules and stimulatory antibodies to reg receptor | |
| CN121693514A (zh) | 含有Braf肽两亲分子的组合物及其使用方法 | |
| WO2026055636A1 (en) | Peptides and compositions for improving glucose levels | |
| EP4720111A1 (en) | Compositions containing p53 peptide amphiphiles and methods of use thereof | |
| US20190330289A1 (en) | Generation of brain and spinal cord neurons, cardiac myocytes, renal nephrons and hepatocytes using reg peptides, peptidomimetics, small molecules and stimulatory antibodies to reg receptor | |
| KR20260027131A (ko) | 폴리뉴클레오티드 및 폴리펩티드 양친매성 물질을 함유하는 조성물 및 그 사용 방법 |